- Home
- CVAC vs TBLA Comparison
CVAC vs TBLA Comparison
Compare CVAC & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVAC | TBLA |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | TBLA |
|---|---|---|
| Price | $5.12 | $3.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $6.83 | $4.50 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 11-24-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | 0.08 |
| Revenue | $83,000,117.00 | ★ $1,880,771,000.00 |
| Revenue This Year | N/A | $11.25 |
| Revenue Next Year | $23.40 | $5.55 |
| P/E Ratio | ★ $5.47 | $50.70 |
| Revenue Growth | N/A | ★ 10.96 |
| 52 Week Low | $2.48 | $2.50 |
| 52 Week High | $5.72 | $4.30 |
Technical Indicators
Market Signals| Indicator | CVAC | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 56.98 |
| Support Level | $5.11 | $3.93 |
| Resistance Level | $5.23 | $4.15 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 30.83 | 37.93 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.